{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:55:23Z","timestamp":1790884523233,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.psyneuen.2021.105219","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T12:41:45Z","timestamp":1617453705000},"page":"105219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Thyroid axis activity and dopamine function in depression"],"prefix":"10.1016","volume":"128","author":[{"given":"Fabrice","family":"Duval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Mokrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Danila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Gonzalez","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.","family":"Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic C.","family":"Jeanjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2021.105219_bib1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/sj.mp.4001364","article-title":"Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression","volume":"8","author":"Alkemade","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"317","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.psyneuen.2021.105219_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2021.105219_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Boadie","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archpsyc.1981.01780260017001","article-title":"A specific laboratory test for the diagnosis of melancholia: standardisation, validation, and clinical utility","volume":"38","author":"Carroll","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.1983.tb03211.x","article-title":"Dopaminergic modulation of TSH and its subunits: in vivo and in vitro studies","volume":"18","author":"Cooper","year":"1983","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2021.105219_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.31887\/DCNS.2002.4.4\/hcorrea","article-title":"Research on serotonin and suicidal behavior: neuroendocrine and molecular approaches","volume":"4","author":"Corr\u00eaa","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2021.105219_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/physrev.00039.2016","article-title":"Neuroimmune interactions: from the brain to the immune system and vice versa","volume":"98","author":"Dantzer","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.psyneuen.2021.105219_bib9","doi-asserted-by":"crossref","unstructured":"Duval, F., 2016. Endocrinologie et psychiatrie. Encycl. M\u00e9d. Chir. Elsevier, Paris, 20 pp., Psychiatrie, 37\u2013640-A-10.","DOI":"10.1016\/j.spsy.2016.03.004"},{"key":"10.1016\/j.psyneuen.2021.105219_bib10","first-page":"166","article-title":"Thyroid axis activity in depression","volume":"4","author":"Duval","year":"2018","journal-title":"Ann. Thyroid Res."},{"key":"10.1016\/j.psyneuen.2021.105219_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.1990.01810170043007","article-title":"Difference between evening and morning thyrotropin responses to protirelin in major depressive episode","volume":"47","author":"Duval","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archpsyc.1996.01830090081012","article-title":"Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode","volume":"53","author":"Duval","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0306-4530(99)00022-0","article-title":"Thyroid axis activity and serotonin function in major depressive episode","volume":"24","author":"Duval","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.31887\/DCNS.2002.4.4\/fduval","article-title":"Interaction between the serotonergic system and HPA and HPT axes in patients with major depression: implications for pathogenesis of suicidal behavior","volume":"4","author":"Duval","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2021.105219_bib15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.psyneuen.2006.04.003","article-title":"Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates","volume":"31","author":"Duval","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.psyneuen.2017.07.488","article-title":"Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients","volume":"85","author":"Duval","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.533872","article-title":"Dopaminergic, noradrenergic, adrenal, and thyroid abnormalities in psychotic and affective disorders","volume":"11","author":"Duval","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2021.105219_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.102.044040","article-title":"The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics","volume":"305","author":"Gary","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2021.105219_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psyneuen.2021.105219_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib22","series-title":"Anatomical Studies of the Dopamine System in the Hypothalamus and the Pituitary Gland. Thesis for doctoral degree (PhD)","author":"Hellysaz","year":"2018"},{"key":"10.1016\/j.psyneuen.2021.105219_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2008.09.004","article-title":"The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis","volume":"121","author":"Kamath","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.psyneuen.2021.105219_bib24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1517\/13543776.2011.623127","article-title":"Novel thyrotropin releasing hormone analogs: a patent review","volume":"21","author":"Khomane","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.psyneuen.2021.105219_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-8993(90)90049-H","article-title":"Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo","volume":"536","author":"Kreutz","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2021.105219_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/endo-100-2-496","article-title":"On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat","volume":"100","author":"Krulich","year":"1977","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A review of the receptor-binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.psyneuen.2021.105219_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0278-5846(88)90033-4","article-title":"Apomorphine in the evaluation of dopaminergic function in man","volume":"12","author":"Lal","year":"1988","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/ajp.139.4.405","article-title":"Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review","volume":"139","author":"Loosen","year":"1982","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.psyneuen.2021.105219_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-8993(97)01550-3","article-title":"Glucocorticoids stimulate TRH and c-fos\/c-jun gene co- expression in cultured hypothalamic neurons","volume":"791","author":"Luo","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2021.105219_bib31","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0537","article-title":"The serotonergic system in mood disorders and suicidal behaviour","volume":"368","author":"Mann","year":"2013","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.psyneuen.2021.105219_bib32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpsyc.1984.01790160098013","article-title":"Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders","volume":"41","author":"Meltzer","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2021.105219_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0306-4530(94)00065-4","article-title":"Multihormonal responses to apomorphine in mental illness","volume":"20","author":"Mokrani","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104831","article-title":"Are the thyroid and adrenal system alterations linked in depression?","volume":"122","author":"Mokrani","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2019.02.009","article-title":"Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients","volume":"112","author":"Monreal","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2021.105219_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0306-4530(01)00021-X","article-title":"Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality","volume":"26","author":"Pitchot","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12020-016-1107-2","article-title":"Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland","volume":"57","author":"Pivonello","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.psyneuen.2021.105219_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.autrev.2014.09.001","article-title":"The importance of cytokines and autoantibodies in depression","volume":"14","author":"Postal","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.psyneuen.2021.105219_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0143-4179(93)90044-B","article-title":"The role of dopamine receptors in the release of thyrotropin-releasing hormone from the rat striatum and nucleus accumbens: an in vitro study","volume":"25","author":"Przegali\u0144ski","year":"1993","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psyneuen.2021.105219_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbr.2016.03.031","article-title":"TRH injected into the nucleus accumbens shell releases dopamine and reduces feeding motivation in rats","volume":"306","author":"Puga","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2021.105219_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchemneu.2019.04.002","article-title":"Distribution of D1 and D2 receptor-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in the rat","volume":"98","author":"Ran","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.psyneuen.2021.105219_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2265.1979.tb03028.x","article-title":"Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in normal man","volume":"10","author":"Scanlon","year":"1979","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2021.105219_bib44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.psyneuen.2005.04.015","article-title":"AVP- and OT-neurophysins response to apomorphine and clonidine in major depression","volume":"30","author":"Scantamburlo","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105219_bib45","first-page":"131","article-title":"New studies and perspectives on the noradrenergic receptor system in depression: effects of the \u03b12-adrenergic agonist clonidine","volume":"19","author":"Siever","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105219_bib46","first-page":"1","article-title":"Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis","volume":"2019","author":"Tundo","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105219_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-0327(90)90018-4","article-title":"The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST","volume":"19","author":"Wiedermann","year":"1990","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2021.105219_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2265.1991.tb00928.x","article-title":"Dopamine. The dopamine D2 receptor and pituitary tumour","volume":"35","author":"Wood","year":"1991","journal-title":"Clin. Endocrinol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:11:38Z","timestamp":1759684298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453021000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"alternative-id":["S0306453021000937"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105219","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid axis activity and dopamine function in depression","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105219"}}